Research Coverage of Japanese Listed Companies, Shared Research Inc

Shared Research

Research Coverage of Japanese Listed Companies

Shared Research Inc

Pioneering research coverage of Japanese listed companies. Now customizable and interactive for global institutional investors. Corporate access reimagined.

Equity Bottom-Up

<ul><li>Sales increased 9.9% YoY to JPY644.6bn, driven by strong overseas sales of dialyzer and dialysis-related products.</li><li>Operating profit rose 19.1% YoY to JPY26.6bn, despite increased unrealized profit deductions and higher provision for doubtful accounts.</li><li>Recurring profit decreased 44.6% YoY to JPY10.8bn, impacted by JPY5.4bn forex losses and increased equity in losses of affiliates.</li></ul>

Sales increased 9.9% YoY to JPY644.6bn, driven by strong overseas sales of dialyzer and dialysis-related products.Operating profit rose 19.1% YoY to JPY26.6bn, despite increased unrealized profit deductions and higher provision for doubtful accounts.Recurring profit decreased 44.6% YoY to JPY10.8bn, impacted by JPY5.4bn forex losses and increased equity in losses of affiliates.

Nipro Corp (8086 JP): Full-year FY03/25 flash update

<ul><li>Consolidated sales increased by 8.4% YoY, driven by strong performance in Medical-Related, Pharmaceutical-Related, and PharmaPackaging businesses.</li><li>Operating profit declined 21.1% YoY due to rising raw material prices, increased labor costs, and higher SG&A expenses.</li><li>Recurring profit decreased 27.9% YoY due to higher interest expenses and increased equity in losses of affiliates.</li></ul>

Consolidated sales increased by 8.4% YoY, driven by strong performance in Medical-Related, Pharmaceutical-Related, and PharmaPackaging businesses.Operating profit declined 21.1% YoY due to rising raw material prices, increased labor costs, and higher SG&A expenses.Recurring profit decreased 27.9% YoY due to higher interest expenses and increased equity in losses of affiliates.

Nipro Corp (8086 JP): Q1 FY03/25 flash update

Japan

NIPRO CORPORATION manufactures medical products.  The Company's products include artificial dialysis and blood transfusion equipment, hypodermic syringes, and glass products for medical use.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Nipro Corp (8086 JP)